Acquisitions10 Feb 2026, 05:34 am
MPS Ltd Completes Acquisition of Unbound Medicine, Inc., USA
AI Summary
MPS Ltd has successfully completed the acquisition of 100% stake in Unbound Medicine, Inc., USA, through its wholly-owned subsidiary MPS North America LLC. The total consideration for the acquisition is USD 16.50 million, payable in accordance with the terms and conditions set out in the Stock Purchase Agreement and other definitive transaction documents. Unbound Medicine, Inc., USA has become a wholly-owned step-down subsidiary of MPS Limited with effect from the date of completion.
Key Highlights
- MPS North America LLC, a wholly-owned subsidiary of MPS Limited, has completed the acquisition of 100% stake in Unbound Medicine, Inc., USA
- The total consideration for the acquisition is USD 16.50 million
- The acquisition is subject to customary adjustments and was completed upon satisfaction of customary closing conditions
- Unbound Medicine, Inc., USA has become a wholly-owned step-down subsidiary of MPS Limited with effect from the date of completion
- The acquisition details have been disclosed as required under SEBI Listing Regulations and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated 30 January 2026